Skip to content
Portal Living Magazine

Zimbabwe Declines ‘Unbalanced’ American Healthcare Assistance Package Because of Information Apprehensions

Medical funding image
The offered US funding would have supported initiatives for HIV/Aids treatment and prevention, tuberculosis, and malaria.

Zimbabwe has rejected a substantial American healthcare agreement valued at 367 million US dollars (£272m) spanning five years because of Washington's insistence on confidential information.

This move was revealed after a official document from December was disclosed, which showed Head of State Emmerson Mnangagwa believed the arrangement was "lopsided".

A government spokesman later clarified that the United States was seeking genetic material for scientific study and commercial purposes while refused to share the benefits from any future vaccines.

"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont publicly.

The US Embassy indicated the US had provided over $1.9bn for health programmes to Zimbabwe during the past twenty years.

A physicians' group in Zimbabwe has appealed for further negotiations to find a deal suitable to all parties so the country's vital HIV treatment initiative can continue.

Broader Background

This rejection comes after a comparable case in Kenya, where a court blocked a related deal with the US after concerns were raised about the safety of citizens' medical information.

After returning to the presidency last year, US President Donald Trump has slashed foreign aid and closed the key foreign aid agency.

USAID had administered assistance for the American government, but Trump argued its expenditure was "inefficient" and his government was pursuing government-to-government agreements to enhance transparency and accountability.

According to statements, 16 African countries have to date signed these new health pacts, representing more than $18.3bn in committed funds.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "HIV/Aids treatment and prevention, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".

"We are confident this collaboration could have provided significant advantages for Zimbabwean communities, especially the 1.2 million presently receiving antiretroviral therapy via American-funded initiatives," Tremont added.

However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".

"The proposal required Zimbabwe to provide its genetic material and health information for a long time, with no equivalent guarantee of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," he stated.

"Put simply, our nation would provide the basic resources for scientific discovery without any certainty that the final treatments would be available to our population if a future disease outbreak arise."

Sovereignty and Global Health

He also said that the American exit from the global health body and its push of bilateral deals were undermining structures already established via the global organization.

Mangwana gave as an example its Pathogen Access and Benefit Sharing framework designed to deal with potential pandemics.

"This framework is intended to guarantee that when a country contributes its samples, the benefits – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."

These objections regarding the US deal "should not be misconstrued as anti-American sentiment," he added.

"We welcome ongoing discussions with our American counterparts on how future collaboration could be arranged in a manner that respects the sovereignty and interests of both nations."

Medical Community Reaction

The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that talks should continue given that much of the country's HIV programmes relied on international support.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can frequently be addressed through detailed discussion and mutually agreed protections," the group added.

The situation emphasises the continuing tensions between receiving much-needed foreign assistance and protecting a country's data in an ever more data-driven world.

The writer

Melissa Mejia

Lena is a lifestyle journalist with a passion for Scandinavian design and sustainable living.

Portal Living Magazine

Type to search articles.